Zaloguj Zarejestruj się zadarmo

Novabay Pharmaceuticals Inc organizacji Marża brutto

Jaka jest wartość Marża brutto organizacji Novabay Pharmaceuticals Inc?

Wartość Marża brutto organizacji Novabay Pharmaceuticals Inc to 53.61%

Jaka jest definicja Marża brutto?



Marża brutto to różnica między przychodem a kosztem sprzedaży towarów podzielona przez przychód i wyrażona w procentach.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Marża brutto firm w Health Care sektor na NYSEMKT w porównaniu do Novabay Pharmaceuticals Inc

Czym się zajmuję organizacja Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Firmy z marża brutto podobne do Novabay Pharmaceuticals Inc